Report Summary
Eternity Insights has published a new study on Global NGS-based RNA-seq Market focusing on key segments as by Type (SBS,SMRT, Other), by Application (Transcriptome Epigenetics,Small RNA, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global NGS-based RNA-seq Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
NGS-based RNA-seq Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global NGS-based RNA-seq Market Size, 2018-2028 (USD Million)
To learn more about this report
Global NGS-based RNA-seq Market Segmentation:
NGS-based RNA-seq Market, By Type
NGS-based RNA-seq Market, By Application
- Transcriptome Epigenetics
- Small RNA
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global NGS-based RNA-seq market in terms of demand generation. The NGS-based RNA-seq market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for NGS-based RNA-seq market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global NGS-based RNA-seq Market Taxonomy:
To learn more about this report
Global NGS-based RNA-seq Market Competitive Landscape
The global NGS-based RNA-seq market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Illumina
- Thermo Fisher Scientific
- Pacific Biosciences Of California
- Qaigen
- F. Hoffmann-La Roche
- Agilent Technologies
- Oxford Nanopore Technologies
- Perkinelmer
- Eurofins Scientific
- Gatc Biotech
- Macrogen
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
Report Attributes |
Details |
The market size value in 2021 |
USD XX.XX Million |
CAGR (2021 - 2028) |
XX.XX % |
The Revenue forecast in 2028 |
USD XX.XX Million |
Base year for estimation |
2021 |
Historical data |
2018-2019 |
Forecast period |
2022-2028 |
Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
By Type Outlook |
SBS,SMRT, Other |
By Application Outlook |
Transcriptome Epigenetics,Small RNA, Other |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled |
Illumina,Thermo Fisher Scientific,Pacific Biosciences Of California,Qaigen,F. Hoffmann-La Roche,Agilent Technologies,Oxford Nanopore Technologies,Perkinelmer,Eurofins Scientific,Gatc Biotech,Macrogen |
Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global NGS-based RNA-seq Market Size Growth Rate by Type (2019-2025)
1.3.2 SBS
1.3.3 SMRT
1.4 Market Segment by Application
1.4.1 Global NGS-based RNA-seq Market Share by Application (2019-2025)
1.4.2 Transcriptome Epigenetics
1.4.3 Small RNA
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global NGS-based RNA-seq Production Value 2014-2025
2.1.2 Global NGS-based RNA-seq Production 2014-2025
2.1.3 Global NGS-based RNA-seq Capacity 2014-2025
2.1.4 Global NGS-based RNA-seq Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global NGS-based RNA-seq Market Size CAGR of Key Regions
2.2.2 Global NGS-based RNA-seq Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global NGS-based RNA-seq Capacity by Manufacturers
3.1.2 Global NGS-based RNA-seq Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 NGS-based RNA-seq Revenue by Manufacturers (2014-2019)
3.2.2 NGS-based RNA-seq Revenue Share by Manufacturers (2014-2019)
3.2.3 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)
3.3 NGS-based RNA-seq Price by Manufacturers
3.4 Key Manufacturers NGS-based RNA-seq Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into NGS-based RNA-seq Market
3.6 Key Manufacturers NGS-based RNA-seq Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 SBS Production and Production Value (2014-2019)
4.1.2 SMRT Production and Production Value (2014-2019)
4.2 Global NGS-based RNA-seq Production Market Share by Type
4.3 Global NGS-based RNA-seq Production Value Market Share by Type
4.4 NGS-based RNA-seq Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global NGS-based RNA-seq Consumption by Application
6 Production by Regions
6.1 Global NGS-based RNA-seq Production (History Data) by Regions 2014-2019
6.2 Global NGS-based RNA-seq Production Value (History Data) by Regions
6.3 United States
6.3.1 United States NGS-based RNA-seq Production Growth Rate 2014-2019
6.3.2 United States NGS-based RNA-seq Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States NGS-based RNA-seq Import & Export
6.4 European Union
6.4.1 European Union NGS-based RNA-seq Production Growth Rate 2014-2019
6.4.2 European Union NGS-based RNA-seq Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union NGS-based RNA-seq Import & Export
6.5 China
6.5.1 China NGS-based RNA-seq Production Growth Rate 2014-2019
6.5.2 China NGS-based RNA-seq Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China NGS-based RNA-seq Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 NGS-based RNA-seq Consumption by Regions
7.1 Global NGS-based RNA-seq Consumption (History Data) by Regions
7.2 United States
7.2.1 United States NGS-based RNA-seq Consumption by Type
7.2.2 United States NGS-based RNA-seq Consumption by Application
7.3 European Union
7.3.1 European Union NGS-based RNA-seq Consumption by Type
7.3.2 European Union NGS-based RNA-seq Consumption by Application
7.4 China
7.4.1 China NGS-based RNA-seq Consumption by Type
7.4.2 China NGS-based RNA-seq Consumption by Application
7.5 Rest of World
7.5.1 Rest of World NGS-based RNA-seq Consumption by Type
7.5.2 Rest of World NGS-based RNA-seq Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Illumina
8.1.1 Illumina Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of NGS-based RNA-seq
8.1.4 NGS-based RNA-seq Product Introduction
8.1.5 Illumina Recent Development
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of NGS-based RNA-seq
8.2.4 NGS-based RNA-seq Product Introduction
8.2.5 Thermo Fisher Scientific Recent Development
8.3 Pacific Biosciences Of California
8.3.1 Pacific Biosciences Of California Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of NGS-based RNA-seq
8.3.4 NGS-based RNA-seq Product Introduction
8.3.5 Pacific Biosciences Of California Recent Development
8.4 Qaigen
8.4.1 Qaigen Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of NGS-based RNA-seq
8.4.4 NGS-based RNA-seq Product Introduction
8.4.5 Qaigen Recent Development
8.5 F. Hoffmann-La Roche
8.5.1 F. Hoffmann-La Roche Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of NGS-based RNA-seq
8.5.4 NGS-based RNA-seq Product Introduction
8.5.5 F. Hoffmann-La Roche Recent Development
8.6 Agilent Technologies
8.6.1 Agilent Technologies Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of NGS-based RNA-seq
8.6.4 NGS-based RNA-seq Product Introduction
8.6.5 Agilent Technologies Recent Development
8.7 Oxford Nanopore Technologies
8.7.1 Oxford Nanopore Technologies Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of NGS-based RNA-seq
8.7.4 NGS-based RNA-seq Product Introduction
8.7.5 Oxford Nanopore Technologies Recent Development
8.8 Perkinelmer
8.8.1 Perkinelmer Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of NGS-based RNA-seq
8.8.4 NGS-based RNA-seq Product Introduction
8.8.5 Perkinelmer Recent Development
8.9 Eurofins Scientific
8.9.1 Eurofins Scientific Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of NGS-based RNA-seq
8.9.4 NGS-based RNA-seq Product Introduction
8.9.5 Eurofins Scientific Recent Development
8.10 Gatc Biotech
8.10.1 Gatc Biotech Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of NGS-based RNA-seq
8.10.4 NGS-based RNA-seq Product Introduction
8.10.5 Gatc Biotech Recent Development
8.11 Macrogen
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global NGS-based RNA-seq Capacity, Production Forecast 2019-2025
9.1.2 Global NGS-based RNA-seq Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global NGS-based RNA-seq Production and Value Forecast by Regions 2019-2025
9.2.2 Global NGS-based RNA-seq Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global NGS-based RNA-seq Production Forecast by Type
9.7.2 Global NGS-based RNA-seq Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 NGS-based RNA-seq Sales Channels
10.2.2 NGS-based RNA-seq Distributors
10.3 NGS-based RNA-seq Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer